SCHEMBL17831774

SCHEMBL17831774

N#Cc1cccc(-c2nc(-c3cc(-n4c5ccccc5c5ccc(-n6c7ccccc7c7ccccc76)cc54)cc(-n4c5ccccc5c5ccc(-n6c7ccccc7c7ccccc76)cc54)c3)nc3ccc4ccccc4c23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 13/20 0.39
CYP3A4 P08684 12/20 0.39
CYP2D6 P10635 9/20 0.39
CLK4 Q9HAZ1 8/20 0.39
ALDH1A1 P00352 7/20 0.39
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
LMNA P02545 6/20 0.39
CYP2C19 P33261 6/20 0.39
HSD17B10 Q99714 6/20 0.39
TSHR P16473 6/20 0.39
MAPK1 P28482 5/20 0.39
CYP2C9 P11712 5/20 0.39
ADORA2A P29274 2/20 0.39
TP53 P04637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
USP2 O75604 7/20 0.37
ALOX15 P16050 1/20 0.37
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17831796 0.94 CYP1A2 (0.39) CYP1A2CYP3A4CYP2D6CLK4ALDH1A1
SCHEMBL17831787 0.90 CYP1A2 (0.38) CYP1A2CYP3A4CYP2D6CLK4ALDH1A1
SCHEMBL17831772 0.89 CYP1A2 (0.39) CYP1A2CYP3A4CYP2D6CLK4ALDH1A1
SCHEMBL17831784 0.87 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CLK4ALDH1A1
SCHEMBL17831800 0.86 CYP1A2 (0.40) CYP1A2CYP3A4CYP2D6CLK4ALDH1A1
SCHEMBL17829183 0.84 FLT3 (0.32) CYP1A2CYP3A4ALDH1A1LMNACYP2C19
SCHEMBL17991170 0.83 ADORA2A (0.36) CYP1A2CYP3A4CYP2D6CLK4ALDH1A1
SCHEMBL17831773 0.81 ABCG2 (0.32) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL17829161 0.81 ABCG2 (0.33) CYP1A2CYP3A4ALDH1A1LMNACYP2C19
SCHEMBL17828992 0.80 ATM (0.40) CYP1A2ALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9508939-B2 Compound and organic electroluminescent element produced using same IDEMITSU KOSAN CO., LTD. (JP) 2016-11-29 US disclosed
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172604-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT PRODUCED USING SAME L1CAM, LEF1, EML4 CYP1A2 1870/4885CYP3A4 2550/4885CYP2D6 3946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.